"Intestinal Fistula" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An abnormal anatomical passage between the INTESTINE, and another segment of the intestine or other organs. External intestinal fistula is connected to the SKIN (enterocutaneous fistula). Internal intestinal fistula can be connected to a number of organs, such as STOMACH (gastrocolic fistula), the BILIARY TRACT (cholecystoduodenal fistula), or the URINARY BLADDER of the URINARY TRACT (colovesical fistula). Risk factors include inflammatory processes, cancer, radiation treatment, and surgical misadventures (MEDICAL ERRORS).
Descriptor ID |
D007412
|
MeSH Number(s) |
C06.267.550 C06.405.469.471 C23.300.575.185.550
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Intestinal Fistula".
Below are MeSH descriptors whose meaning is more specific than "Intestinal Fistula".
This graph shows the total number of publications written about "Intestinal Fistula" by people in this website by year, and whether "Intestinal Fistula" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Intestinal Fistula" by people in Profiles.
-
Changala M, Laberge J, Kerlan R, Taylor A, Arain M, Kirkwood K. Managing Refractory Postoperative Fistulas as Chronic Wounds Using Video-Assisted Hydrodebridement (VAHD). J Gastrointest Surg. 2019 03; 23(3):608-612.
-
Bhankar H, Goyal S, Zaheer S, Sugandhi N, Mandal AK. Occult Adenoma in Patent Vitellointestinal Duct Presenting as an Umbilical Fistula: Cause for Concern? Fetal Pediatr Pathol. 2016; 35(4):272-6.
-
Magno P, Jim?nez CE, Ortiz Z, Torres EA. Recombinant human granulocyte-macrophage colony stimulating factor (sargramostim) as an alternative therapy for fistulizing Crohn's disease. P R Health Sci J. 2010 Mar; 29(1):60-5.